Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guchong Granules for Ovulatory Dysfunctional Uterine Bleeding With Menorrhagia
CTR20180033Phase 3Active
- Sponsor
- Nanjing Dadong Pharmaceutical Technology
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Guchong in dysfunctional uterine bleeding (DUB), sponsored by Nanjing Dadong Pharmaceutical Technology. Started Jun 2018; status: active.
02
Drugs
Guchong
03
Conditions
dysfunctional uterine bleeding (DUB)
Beyond the preview
Go deeper on CTR20180033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180033.